Universal Health Services, Inc.

Universal Health Services, Inc.

UHS

$180.65

Updated: 03/11/2026, 01:56:37

Market Cap
$9.34B
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US

No historical data available

Company Profile

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

USD
NYSE
CEO: Marc D. Miller
Employees: 101,500
https://uhs.com
Asset Summaries
Latest generated summaries for UHS

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
UHS-10-k-fy2025.html7.6 MBtext/htmlENFiled 25/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 50 KPI observations

Revenue

17.4B

FY 2025 · Reported

Net income

1.5B

FY 2025 · Reported

Gross margin

N/A

FY — · Reported

Free cash flow

0.8B

FY 2025 · Calculated

R&D intensity

N/A

FY — · Reported

Share repurchases

1.0B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Hospital service lines
Hospital service lines and management services

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Principal business

Owns/operates acute care hospitals, outpatient facilities and behavioral health facilities

99%
Source evidence
“Our principal business is owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities.”

Principal business

Acute care hospitals/outpatient facilities and behavioral health care facilities

99%
Source evidence
“Our principal business is owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities.”

Facility breakdown by segment

US acute care: 29 inpatient hospitals, 35 FSEDs, 13 outpatient centers, 1 surgical hospital; behavioral health: 346 inpatient / 119 outpatient (US 182/110, U.K. 161/2, PR 3/7)

98%
Source evidence
“Behavioral health care facilities (346 inpatient facilities and 119 outpatient facilities)”

Sources of revenue / payers

Private insurers/managed care, Medicare, state Medicaid programs, and direct patient payments

97%
Source evidence
“We receive payments for services rendered from private insurers, including managed care plans, the federal government under the Medicare program, state governments under their respective Medicaid programs and directly from patients.”

Government payer dependency including UK NHS

Significant revenue from Medicare/Medicaid; vast majority of UK behavioral health net revenues from governmental payers; managed care payers demanding lower rates

97%
Source evidence
“the vast majority of the net revenues generated at our behavioral health facilities located in the United Kingdom are derived from governmental payers.”

Medicare Advantage premiums via commercial insurer

Majority of commercial insurer revenues relate to Medicare Advantage premiums determined by CMS; risk score adjustments result in retroactive premium adjustments

90%
Source evidence
“The majority of the revenues generated by our commercial health insurer conducting business in certain acute care markets relate to Medicare Advantage premiums”

Hospital service lines

General and specialty surgery, internal medicine, obstetrics, ER care, radiology, oncology, diagnostic, coronary, pediatric, pharmacy and behavioral health services

97%
Source evidence
“Services provided by our hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.”

Hospital service lines and management services

Services include general/specialty surgery, internal medicine, obstetrics, ER, radiology, oncology, diagnostics, coronary care, pediatrics, pharmacy and behavioral health; central management services provided to facilities

95%
Source evidence
“Services provided by our hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.”

U.K. behavioral health revenues and assets

U.K. behavioral health net revenues $1.001B (2025) vs $880M (2024); total assets $1.531B vs $1.358B

97%
Source evidence
“Our behavioral health care facilities located in the U.K. generated net revenues of approximately $1.001 billion in 2025 and $880 million in 2024.”

State Medicaid supplemental payment program revenues

Receives ~$100M+ annual Medicaid revenues from each of 14 states/DC; most programs approved year-to-year with no assurance of continuation

97%
Source evidence
“We receive annual Medicaid revenues of approximately $100 million, or greater, from each of Texas, California, Nevada, Washington, D.C., Illinois, Pennsylvania, Kentucky, Tennessee, Virginia, Massachusetts, Michigan, Florida, Mississippi and Washington.”

Revenue mix: acute care vs behavioral health

Acute care + commercial insurer ~57% of consolidated net revenues; behavioral health + commercial insurer ~43% in each of 2025 and 2024

98%
Source evidence
“Net revenues from our acute care hospitals, outpatient facilities and commercial health insurer accounted for approximately 57% of our consolidated net revenues during each of 2025 and 2024. Net revenues from our behavioral health care facilities and commercial health insurer accounted for approximately 43%”

Revenue mix acute care vs behavioral health

Acute care ~57% of consolidated net revenues; behavioral health ~43% in each of 2025 and 2024

98%
Source evidence
“Net revenues from our acute care hospitals, outpatient facilities and commercial health insurer accounted for approximately 57% of our consolidated net revenues during each of 2025 and 2024.”

Positioning and strategy

Hospital utilization factors

Utilization driven by quality, market position, physician base, technology, demographics, reimbursement availability and managed care penetration

92%
Source evidence
“the most important factors relating to the overall utilization of a hospital include the quality and market position of the hospital and the number, quality and specialties of physicians providing patient care within the facility”

Outpatient shift demand driver

Cost containment and technology advances drive shift to outpatient/ambulatory care

90%
Source evidence
“Pressures to contain healthcare costs and technological developments allowing more procedures to be performed on an outpatient basis have led payers to demand a shift to ambulatory or outpatient care wherever possible.”

Growth via acquisitions and partnerships

Rational growth around core businesses; behavioral health partnerships with non-UHS acute care hospitals; divestitures of non-contributing facilities

95%
Source evidence
“In recent years our behavioral health services segment has been focused on efforts to partner with non-UHS acute care hospitals to help operate their behavioral health services.”

Outpatient expansion

Emphasizing expansion of outpatient services in response to payers' shift to ambulatory care

95%
Source evidence
“We are responding to this trend by emphasizing the expansion of outpatient services.”

Risks, financing, and outlook

Senior notes outstanding: $800M 2.65% due 2030, $700M 1.65% due 2026, $500M 2.65% due 2032, $500M 4.625% due 2029, $500M 5.05% due 2034

Five senior note tranches: $800M 2.65% due 2030; $700M 1.65% due 2026; $500M 2.65% due 2032; $500M 4.625% due 2029; $500M 5.05% due 2034 (latter two issued Sep 2024).

95%
Source evidence
“In September, 2024, we completed the offering of $500 million aggregate principal amount of 5.050% Senior Notes due in 2034.”

Credit agreement tenth amendment: $1.3B revolver, $1.2B Tranche A term loan due 2029

Tenth amendment (Sep 26, 2024): maturity extended to Sep 26, 2029; revolver increased to $1.3B ($889M available at 12/31/2025); Tranche A term loan reduced to $1.2B ($1.16B outstanding).

95%
Source evidence
“an extension of the maturity date to September 26, 2029; (ii) a $100 million increase in the revolving credit facility to $1.3 billion of aggregate borrowing capacity”

Estimated overall increase from final IPPS 2026 rule approximately 2.7%

IPPS 2026 final rule: 3.3% market basket increase; overall IPPS increase ~1.0% before DSH/outlier adjustments; UHS estimates overall increase ~2.7%.

95%
Source evidence
“we estimate our overall increase from the final IPPS 2026 rule (covering the period of October 1, 2025 through September 30, 2026) will approximate 2.7%.”

IPPS 2025 rule estimated overall increase ~1.2%; IPPS 2024 ~5.4%

IPPS 2025 rule estimated overall increase ~1.2% (period Oct 1, 2024-Sep 30, 2025); IPPS 2024 rule estimated overall increase ~5.4%.

90%
Source evidence
“we estimate our overall increase from the final IPPS 2025 rule (covering the period of October 1, 2024 through September 30, 2025) will approximate 1.2%.”

One Big Beautiful Bill Act Medicaid impact estimate

OBBBA work requirements and provider fee limits expected to reduce aggregate annual net benefit by ~$432M-$480M by 2032, starting with 2028 state fiscal years

98%
Source evidence
“we estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $432 million to $480 million by 2032”

Healthcare fraud and abuse regulation

Subject to anti-kickback, false claims, self-referral and privacy laws; violations can lead to exclusion, fines or repayment

95%
Source evidence
“Providers that are found to have violated any of these laws and regulations may be excluded from participating in government healthcare programs, subjected to significant fines or penalties”

Enhanced premium tax credits expiration / H.R.1834

ACA exchange enhanced premium tax credits expired Dec 31, 2025; H.R.1834 (House-passed Jan 8, 2026) would extend EPTCs three years, under Senate review

95%
Source evidence
“On January 8, 2026, the U.S. House of Representatives passed H.R.1834 to extend for three years the enhanced premium tax credits ("EPTCs") that expired on December 31, 2025, which is currently undergoing review in the Senate.”

Medicare and Medicaid reimbursement regulatory dependence

Medicare/Medicaid funding subject to legislative and regulatory change; certain payments subject to retroactive adjustment from audits

95%
Source evidence
“The funding of both federal Medicare and state Medicaid programs are subject to legislative and regulatory changes.”

ACA Medicaid DSH payment reductions scheduled to begin FFY 2028

The ACA provides for reductions to Medicaid DSH payments which are now scheduled to begin in federal fiscal year 2028.

95%
Source evidence
“The ACA provides for reductions to Medicaid DSH payments which are now scheduled to begin in federal fiscal year 2028.”

Certificates of Need laws

CON laws can block acquisitions/expansions; failure risks sanctions, loss of Medicare/Medicaid reimbursement or license revocation

93%
Source evidence
“Failure to obtain necessary state approval can result in our inability to complete an acquisition, expansion or replacement”

Licensing, accreditation and Medicare/Medicaid certification

Joint Commission accreditation and Medicare/Medicaid certification required for reimbursement

93%
Source evidence
“If any of our facilities were to lose its Joint Commission accreditation or otherwise lose its certification under the Medicare and Medicaid programs, the facility may be unable to receive reimbursement”

Value-based purchasing 2% inpatient payment withhold in FFY 2017 and subsequent years

HHS reduces inpatient hospital payments by 2% for all discharges in FFY 2017 and subsequent years to fund VBP quality incentives; budget-neutral offset applied only in FFY 2022-2023.

90%
Source evidence
“The Legislation requires HHS to reduce inpatient hospital payments for all discharges by 2% in FFY 2017 and subsequent years.”

HAC program imposes 1% Medicare payment reduction on top-quartile hospitals

Hospitals in top 25% of national risk-adjusted HAC rates receive a 1% reduction in total Medicare payments; program suppressed for FY 2023, reinstated in FFY 2024.

90%
Source evidence
“hospitals that fall into the top 25% of national risk-adjusted HAC rates for all hospitals in the previous year will receive a 1% reduction in their total Medicare payments.”

Hospital readmission reduction program penalties up to 3%

HRRP assesses penalties on excess readmissions for heart failure, MI, pneumonia, COPD, THA/TKA and CABG; adjustment factors can be no more than a 3% reduction.

90%
Source evidence
“Readmissions payment adjustment factors can be no more than a 3% reduction.”

Competition from tax-supported/nonprofit hospitals and UK NHS/independent providers

Highly competitive: US rivals with tax exemptions and greater resources; in UK, NHS plus independent sector providers compete for patients

95%
Source evidence
“We also operate health care facilities in the United Kingdom where the National Health Service (the "NHS") is the principal provider of healthcare services. In addition to the NHS, we face competition in the United Kingdom from independent sector providers”

Uninsured/underinsured patients and receivables collection risk

Collection of third-party payer and patient receivables is primary cash source; bad debt risk from uninsured/underinsured growth could harm results

94%
Source evidence
“Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance.”

Price transparency and quality reporting requirements

CMS quality reporting, ACA standard-charge publication and No Surprises Act transparency requirements; poor metrics/pricing could reduce patient volume

92%
Source evidence
“the No Surprises Act, adopted as part of the Consolidated Appropriations Act, 2021 ("CAA"), creates additional price transparency requirements beginning January 1, 2022”

Weather/climate exposure in concentrated states

Wildfires (especially California) and severe storms may disrupt operations and raise commercial property insurance premiums/self-insured retentions

92%
Source evidence
“may cause our commercial property insurance premiums and/or self-insured retentions to increase significantly”

Enhanced exchange subsidies expired December 31, 2025; extension uncertain

IRA-extended exchange subsidies expired December 31, 2025; extension is subject of Congressional budget negotiation and outcome unpredictable.

90%
Source evidence
“These enhanced subsidies expired on December 31, 2025.”

OBBBA Medicaid work requirements expected to reduce coverage and raise uncompensated care

OBBBA applies work and community engagement requirements to a significant percentage of Medicaid beneficiaries; UHS anticipates reduced Medicaid coverage and likely increased uncompensated care.

90%
Source evidence
“We anticipate this change will lead to reductions in Medicaid coverage and likely increases in uncompensated care.”

Collection risk from uninsured patients and patient responsibility

Primary collection risks relate to uninsured patients and the portion of the bill which is the patient's responsibility, primarily co-payments and deductibles

90%
Source evidence
“Our primary collection risks relate to uninsured patients and the portion of the bill which is the patient’s responsibility, primarily co-payments and deductibles.”

Material exposure graph

Medicare and Medicaid programs
Revenue Exposure

U.S. hospital revenues depend heavily on Medicare and Medicaid reimbursement, subject to complex rules, retroactive audits, and legislative funding changes.

Relevance 95·Dependency 90·Confidence 95
Source evidence
“due to the complexities involved in these estimations, actual payments from payers may be different from the amounts we estimate and record”
Medicaid
Revenue Exposure

Significant revenue from Medicaid including state supplemental payment programs (~$100M+ annually from 14 states/DC); OBBBA estimated to cut annual net benefit $432M-$480M by 2032.

Relevance 95·Dependency 85·Confidence 98
Source evidence
“Any significant reduction in federal Medicaid funding to states would likely result in states reducing Medicaid payments to us.”
One Big Beautiful Bill Act
Regulatory Exposure

Work/community service requirements limit Medicaid enrollment; provider fee limits (6% threshold for non-expansion states; declining to 3.5% by FY2032 in expansion states) reduce supplemental payment funding.

Relevance 95·Dependency 82·Confidence 97
Source evidence
“attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditure.”
Medicare and Medicaid programs
Customer Exposure

Medicare and Medicaid are core reimbursement sources; loss of certification would eliminate facility reimbursement.

Relevance 90·Dependency 80·Confidence 93
Source evidence
“We receive payments for services rendered from private insurers, including managed care plans, the federal government under the Medicare program, state governments under their respective Medicaid programs”
One Big Beautiful Bill Act (OBBBA) Medicaid work requirements
Regulatory Exposure

OBBBA work/community engagement requirements for Medicaid beneficiaries are expected to reduce Medicaid coverage and increase uncompensated care for UHS hospitals.

Relevance 90·Dependency 75·Confidence 90
Source evidence
“We anticipate this change will lead to reductions in Medicaid coverage and likely increases in uncompensated care.”
Healthcare labor shortages and wage inflation
Cost Driver

Staffing shortages required expensive temporary personnel and wage enhancements; unfilled behavioral health vacancies forced volume limits, constraining revenue.

Relevance 85·Dependency 78·Confidence 95
Source evidence
“At certain facilities, particularly within our behavioral health care segment, there have been occasions when we were unable to fill all vacant positions and, consequently, we were required to limit patient volumes.”
Medicare and Medicaid fraud and abuse provisions
Regulatory Exposure

Violations could exclude UHS from government healthcare programs, trigger significant fines/penalties or require repayment of previously billed services.

Relevance 85·Dependency 75·Confidence 94
Source evidence
“may be excluded from participating in government healthcare programs, subjected to significant fines or penalties and/or required to repay amounts received from the government for previously billed patient services”
CMS IPPS 2026 final rule
Revenue Exposure

Medicare IPPS rates are a major revenue source; the final 2026 rule is estimated to increase UHS overall payments approximately 2.7%.

Relevance 85·Dependency 70·Confidence 95
Source evidence
“we estimate our overall increase from the final IPPS 2026 rule (covering the period of October 1, 2025 through September 30, 2026) will approximate 2.7%.”
Medicare
Revenue Exposure

Medicare reimbursement subject to statutory/regulatory change; Medicare Advantage funding pressure flows through managed care payers to UHS rates.

Relevance 85·Dependency 70·Confidence 95
Source evidence
“government pressure on managed care organizations through static or reduced funding received by these payers from government sources such as through Medicare Advantage plans will in turn increase the pressure on us to not increase or reduce the rates charged by us”
Exchange subsidies expiration (Dec 31, 2025)
Revenue Exposure

Expiration of enhanced exchange subsidies may reduce insured patient volumes; extension remains subject to Congressional debate.

Relevance 80·Dependency 65·Confidence 85
Source evidence
“These enhanced subsidies expired on December 31, 2025.”
Private insurers and managed care plans
Revenue Exposure

Private insurers, including managed care plans, are a primary payer source alongside Medicare, Medicaid and direct patient payments.

Relevance 75·Dependency 65·Confidence 90
Source evidence
“We receive payments for services rendered from private insurers, including managed care plans”
Outpatient/ambulatory care shift
Demand Driver

Payer cost-containment and technology are shifting procedures to outpatient settings; UHS is responding by expanding outpatient services.

Relevance 75·Dependency 55·Confidence 90
Source evidence
“have led payers to demand a shift to ambulatory or outpatient care wherever possible. We are responding to this trend by emphasizing the expansion of outpatient services.”
Joint Commission accreditation and Medicare/Medicaid certification
Regulatory Exposure

All eligible hospitals are Joint Commission accredited; loss of accreditation or Medicare/Medicaid certification could end facility reimbursement.

Relevance 70·Dependency 70·Confidence 92
Source evidence
“All of our eligible hospitals have been accredited by The Joint Commission.”
Medicare Advantage members
Revenue Exposure

Commercial insurer revenues are driven by CMS-determined Medicare Advantage premiums with risk adjustment and retroactive premium adjustments.

Relevance 70·Dependency 65·Confidence 85
Source evidence
“Risk score adjustments result in retroactive premium adjustments.”
United Kingdom
Revenue Exposure

U.K. behavioral health facilities generated approximately $1.001 billion of net revenues in 2025, a meaningful and growing portion of consolidated revenues.

Relevance 70·Dependency 40·Confidence 95
Source evidence
“Our behavioral health care facilities located in the U.K. generated net revenues of approximately $1.001 billion in 2025 and $880 million in 2024.”
Hospital Value-Based Purchasing program
Revenue Exposure

2% inpatient payment withhold funds quality incentives; budget-neutral offset applied only in FFY 2022-2023, so the withhold applies again from FFY 2024.

Relevance 65·Dependency 55·Confidence 90
Source evidence
“The Legislation requires HHS to reduce inpatient hospital payments for all discharges by 2% in FFY 2017 and subsequent years.”
Hospital Readmission Reduction Program
Revenue Exposure

Excess readmissions for designated conditions can reduce base operating DRG payments by up to 3% per discharge.

Relevance 65·Dependency 55·Confidence 90
Source evidence
“Readmissions payment adjustment factors can be no more than a 3% reduction.”
Uninsured patients
Customer Exposure

Collection risk concentrated in uninsured patients and patient-responsibility balances (co-payments, deductibles) requiring implicit price concession estimates.

Relevance 65·Dependency 50·Confidence 85
Source evidence
“Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance.”
Hospital Acquired Conditions Reduction Program
Revenue Exposure

Top-quartile HAC-rate hospitals face a 1% cut to total Medicare payments; penalty reinstated in FFY 2024 after FY 2023 suppression.

Relevance 60·Dependency 50·Confidence 90
Source evidence
“hospitals that fall into the top 25% of national risk-adjusted HAC rates for all hospitals in the previous year will receive a 1% reduction in their total Medicare payments.”
Certificates of Need laws
Regulatory Exposure

CON approvals are required before hospital capital expenditures, construction, expansion or major new services in certain states; failure can block growth or cost licenses/reimbursement.

Relevance 60·Dependency 50·Confidence 92
Source evidence
“Certain of the states in which we operate hospitals have certificates of need (“CON”) laws as a condition prior to hospital capital expenditures, construction, expansion, modernization or initiation of major new services.”
General and local economic conditions / demographics
Demand Driver

Hospital utilization is affected by economic conditions, managed care penetration, outpatient use, reimbursement availability and local population growth.

Relevance 55·Dependency 40·Confidence 85
Source evidence
“Other factors that affect utilization include general and local economic conditions, market penetration of managed care programs, the degree of outpatient use, the availability of reimbursement programs such as Medicare and Medicaid, and demographic changes such as the growth in local populations.”
Full company information
Latest profile, trading, valuation, and identifier data stored for UHS.
Share price
$180.65
Market cap
$9.34B
Exchange
NYSE
Currency
USD
CEO
Marc D. Miller
Employees
101,500
IPO date
09/07/1981
Beta
1.029
Last dividend
$0.00
Day range
$172.80 – $180.91
52-week range
$140.08 – $246.33
1-day performance
2.61%
1-year performance
28.96%
Current drawdown (1Y)
-26.66%
CIK
0000352915
CUSIP
913903100
ISIN
US9139031002
Created
07/12/2025, 14:52:05
Last update
03/11/2026, 01:56:37

Track Universal Health Services, Inc. with an AI analyst

See which prediction-market events move UHS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to UHS from your Railway `news_articles` table.

Why Is Universal Health Services (UHS) Down 3.6% Since Last Earnings Report?

Zacks Investment Research • STOCK • 27/05/2026, 14:31:13

Universal Health Services, Inc. (UHS) Shareholder/Analyst Call Prepared Remarks Transcript

Seeking Alpha • STOCK • 20/05/2026, 14:20:54

Universal Health Services, Inc. (UHS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 13/05/2026, 00:10:51

Universal Health Services, Inc. (UHS) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 28/04/2026, 14:51:39

Universal Health Services (UHS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research • STOCK • 27/04/2026, 21:01:40

Universal Health Services (UHS) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research • STOCK • 27/04/2026, 20:31:04

Universal Health Services (UHS) Down 9.4% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research • STOCK • 27/03/2026, 13:36:22

Universal Health Services, Inc. (UHS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Seeking Alpha • STOCK • 10/03/2026, 20:30:16

Universal Health Services, Inc. (UHS) Presents at Leerink Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 09/03/2026, 11:08:02

Universal Health Services, Inc. (UHS) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seeking Alpha • STOCK • 03/03/2026, 15:22:18

Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term

Zacks Investment Research • STOCK • 02/03/2026, 11:50:54

Universal Health Services (UHS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research • STOCK • 25/02/2026, 22:30:14